Redmile Group’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History
Bought
Maintained
Sold
Redmile Group's TRIV Position: Q1 2016 in Review
Redmile Group sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 1,462,762 shares — an estimated $9.73M sold.
Redmile Group first reported a position in TRIV in Q2 2014 and held it in 7 quarters. The position peaked at $25.5M in Q3 2014. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.
- Redmile Group reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
- Redmile Group sold 1,462,762 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $9.73M.
- Redmile Group first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 7 quarters.
- Redmile Group's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $25.5M in Q3 2014.
- 0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.
Based on Redmile Group's 13F filing for Q1 2016, filed 16 May 2016.